Live Chat ×
Skip to main content

Presidential Symposium: A Futurist's View - 2016 Annual Meeting Recording

Award Presentation: AES Research Recognition Awards in Basic Science and Clinical Science

This session outlines the current state of epilepsy diagnosis and treatment, then identifies existing roadblocks and speculate on future trends. Key topics for the current and future management of epilepsy include: 1) existing, new and future approaches to epilepsy surgery and devices; 2) development of new antiepileptic and antiepileptogenic medications; 3) how understanding molecular mechanisms in signaling pathways like mTOR, and new and future gene discoveries will influence diagnosis and treatment; 4) how the expanding field of bioinformatics will influence decision making now and in the future; and 5) how current and future brain imaging methods will be applied to epilepsy.

Following participation in this session, learners should be able to:

  • List several molecular pathways that may be altered in people with epilepsy and identify existing treatment(s) that can be applied.
  • Describe the process for the development of new antiepileptic drugs.
  • Delineate the risks and benefits of the currently available surgical approaches to treating people with epilepsy. 
  • Employ bioinformatic methods to create performance improvement projects with existing clinical data.
  • Select the appropriate currently available bioimaging technique(s) to optimize diagnosis and treatment for people with epilepsy.
  • Describe how current and future brain imaging methods can supplement and enhance neuropsychological evaluation and outcomes.
Intermediate and Advanced 

Chair: Michael Privitera, M.D.

Michael Privitera, M.D.

Current and Future Approaches to Surgery and Devices for Epilepsy
Dennis Spencer, M.D.

Harnessing the Power of Bioinformatics in Epilepsy
Tracy Glauser, M.D.

Brain Imaging in Epilepsy Now and in the Future
Jerzy Szaflarski, M.D., Ph.D.

Current and Future Trends in Development of Antiepileptic Drugs
Henrik Klitgaard, Ph.D.

Genes and Signaling Pathways: Future Therapeutic Strategies
The Fritz R. Dreifuss Lecture
Peter Crino, M.D., Ph.D.

Michael Privitera, M.D.

Supported in part by educational grants from Eisai Inc., Lundbeck, UCB, Inc., and Sunovion Pharmaceuticals Inc.

Attendees of the 2016 Annual Meeting have free access to recordings.